Notice of Completion of Series A Funding of Approximately 560 Million Yen

CTBE has completed Series A Funding in January 2023. A total of approximately 560 million yen in series A funding was raised through the following investors.


Waseda Innovation Fund No. 3 Investment Partnership

Teijin Limited

Japan Science and Technology Agency

AXA Life Insurance Co., Ltd.

NextG Investment Business Limited Liability Partnership

Sun Global Co., Ltd.


With this funding, CTBE will accelerate the commercialization of artificial ligaments for anterior cruciate ligament reconstruction surgery.